Home Research Reports Call for Innovative Modes of Treating Chronic Ailments to reinvent the healthcare vertical
Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Call for Innovative Modes of Treating Chronic Ailments to reinvent the healthcare vertical

by gbaf

Cell and tissue culture has evolved in the last few years and continues to do so. It has, in fact, turned out to be one of the indispensable tools in molecular and cellular biology. As such, effects of several drugs and toxins on mutagenesis, biochemistry, carcinogenesis, and physiology of cells could be studied. Based on culture systems and instruments, the cell and tissue culture market spans biosafety cabinets, cryostage equipment, incubators, pipetting instruments, and roller bottle equipment. Type-wise, it’s petri dishes, cell and tissue culture cylinders, cell and tissue spreaders and lifters, tissue grinders for cell and tissue culture, serological pipettes, and likewise.

Amongst the advancements in cell culture is 3D cell culture. 3D cultures are capable of closely mimicking conventional morphology as well as microarchitecture of the organs. As such, they find their presence in “in-vivo model systems” for analyzing the foreign drug’s effect on body organs and tissues. Plus, 3D organotypic structures get generated through biomimetic tissue constructs. This factor has prompted research entities to go for 3D cell culture techniques. These days, 3D tissue-engineered models are being employed for detection of cancer, Covid-19, and several clinical disorders. Technology-wise, 3D cell culture market spans scaffold-based (polymeric scaffolds, hydrogels, micro-patterned surface microplates, and nanofiber-based scaffolds), scaffold-free (hanging drop microplates, microfluidic 3D cell culture, Spheroid-Microplates with ULA coating, and magnetic levitation & 3D bioprinting), and bioreactors. Application-wise, it’s tissue engineering & immunohistochemistry, stem cell research, drug development, and others.

Additionally, growing incidences of neurological diseases, brain tumor, and cancer are driving the demand for Gamma Knife in the surgical centers as minimally invasive surgeries are being preferred. By symptoms, the Gamma Knife market spans vascular disorders, benign tumors, malignant tumors, functional disorders, and ocular diseases. Companies like Samsung have been pretty active in the gamma knife market of late, especially after Samsung Medical Center acquiring the very first Gamma Knife Icon system in the Asia-Pacific in the year 2015.

It’s a known fact that hygiene is the pivot to every surgery. This is where the surgical gowns come into picture. This hygienic clothing does do away with entry of various micro-organisms into surgeons. Product-wise, they span reusable and disposable. These gowns are witnessing a tremendous increase in demand since the outbreak of Covid-19 to be doubly sure that cross-contamination doesn’t happen. Along these lines, Mohawk Industries, in April 2020, joined hands with FSI (Fabric Sources International) for catering to medical needs at Emory Healthcare and Hamilton Medical Center in Atlanta (including surgical gowns).

Cancer supportive care products market is flourishing on the basis of new product launches backed by tech-enabled developments. For instance – Amgen Inc. presents Neulasta. It comes across as human granulocyte CSF’s PEGylated form. Baxter develops a metoclopramide injection known as “REGLAN” injection. Bayer AG has its “Xarelto” incorporating rivaroxaban. Daiichi Sankyo Co. Ltd. has a hydromorphone hydrochloride injection called “Naruvein Injection”. GlaxoSmithKline develops a neurokinin 1 receptor antagonist called “REZONIC”.

Bone marrow transplantation is being recommended for treating advanced stages of Hodgkin lymphomas, leukemia, non-Hodgkin lymphomas, aplastic and sickle cell anemia, multiple myeloma, thalassemia. Based on sources of stem cells or bone marrow, there could be conventional bonne marrow transplant or peripheral stem cell transplant.

Robotic surgery has the basic advantage of performing complex surgeries with utmost precision, that too, in the anatomical areas tough to be reached by the surgeons. Thus, the healthcare vertical is being driven by automation. Intuitive Surgical Inc. has its da Vinci surgical system, which is amongst the well-known robotic surgical systems across the globe. Zimmer Biomet, in January 2019, did receive clearance from the US FDA for ROSA Knee System with respect to robotically-assisted total knee replacement surgeries.

World Population Prospects, in the year 2019, stated that close to 17% of the global population will cross 65 in the next 3 decades. Plus, the WHO states that in the same year more than 2 Bn people around the world contracted disabilities. These figures speak volumes of the need for stair lifts in the long run. By rail orientation, they are curved and straight. By user orientation, they are integrated, standing, and seated. Installation-wise, they could be indoor and outdoor.

Wound cleanser products serve chronic wounds, traumatic injuries (due to mishaps), and the increasing number of surgeries. The end-users are home healthcare centers, community medical centers, ambulatory surgical centers, hospital outpatient settings, and hospital inpatient settings. Plastic wound retractors are being asked for where bariatric surgery, hernia, and C-Section are performed. However, using them is still a double-edged sword with dearth of laparoscopic surgeons along with post-operative side effects.

Persistence Market Research (PMR) has profiled the key players as follows:

  • Sigma-Aldrich Co LLC
  • Wheaton Industries
  • VWR International LLC
  • Biocompare, Inc.
  • Capitol Scientific, Inc.
  • GE Healthcare Ltd.
  • Elekta AB
  • Halyard Health
  • Bellcross Industries
  • Exact Medical
  • Cardiva Integral Solutions
  • Hartmann AG
  • Verb Surgical, Inc.
  • Medtronic
  • Smith & Nephew
  • TransEnterix Surgical, Inc.
  • ReachBio LLC
  • Conversant Bio
  • Lifeline Cell Technology
  • Lonza Group Ltd.
  • Bruno Independent Living Aids
  • Stannah Lifts Holdings Ltd.
  • Reckitt Benckiser Group plc
  • Derma Sciences Inc.
  • Victor Medical Instruments Co., Ltd.
  • Cooper Surgical

PMR has not missed to state that continuous innovations on the count of cancer treatment (and also the other chronic ailments) would take this arm of healthcare industry by storm in the next decade.

You may also like